⌘K

Loading dashboard...

⚗️

PEPTIDEENGINEBiohacking & Longevity

⌘K

🏥 Clinical Resources for Healthcare Providers

Evidence-based protocols, prescribing guidelines, and clinical decision support for medical professionals

Clinical

Professional

Evidence-Based

Protocols

For Healthcare Professionals

This section contains clinical-grade information intended for licensed healthcare providers. Content includes prescribing guidelines, drug interactions, monitoring protocols, and evidence summaries. All recommendations should be adapted to individual patient circumstances.

Quick Access

Prescriber's Guide

Quick reference for dosing & protocols

Evidence Database

Peer-reviewed research summaries

Drug Interactions

Contraindications & interactions

Patient Monitoring

Lab panels & follow-up protocols

Evidence Level Classification

Our evidence grading system follows standard clinical research hierarchies

Strong evidence from multiple RCTs or meta-analyses

Moderate evidence from limited RCTs or well-designed studies

Limited evidence from observational studies or case series

Expert opinion or mechanistic rationale only

Clinical Protocols by Category

Tissue Repair

BPC-157 Acute Injury Protocol

Tendon/ligament injury

Evidence: Level B

TB-500 Systemic Healing Protocol

Multiple site injuries

Evidence: Level B

Post-Surgical Recovery Protocol

Accelerated wound healing

Evidence: Level C

Metabolic

Semaglutide Titration Protocol

Obesity, T2DM

Evidence: Level A

Tirzepatide Weight Management

Obesity, metabolic syndrome

Evidence: Level A

MOTS-c Metabolic Optimization

Metabolic dysfunction

Evidence: Level C

Cognitive

Semax Cognitive Enhancement

Cognitive decline, TBI recovery

Evidence: Level B

Cerebrolysin Neurorehabilitation

Stroke, TBI, dementia

Evidence: Level A

Selank Anxiety Protocol

GAD, stress-related disorders

Evidence: Level B

Hormonal

CJC-1295/Ipamorelin GH Optimization

GH deficiency, anti-aging

Evidence: Level B

Tesamorelin Lipodystrophy

HIV lipodystrophy, visceral fat

Evidence: Level A

PT-141 Sexual Dysfunction

Hypoactive sexual desire

Evidence: Level A

Key Clinical Considerations

Absolute Contraindications

• Active malignancy: GH secretagogues, TB-500 (angiogenesis)
• Pregnancy/Lactation: Most peptides (insufficient safety data)
• Severe renal impairment: Cerebrolysin, some GLP-1 agonists
• Personal/family history MTC: GLP-1 receptor agonists
• MEN 2 syndrome: GLP-1 receptor agonists

Relative Contraindications

• Diabetic retinopathy: GH secretagogues (monitor closely)
• History of pancreatitis: GLP-1 agonists (use caution)
• Gastroparesis: GLP-1 agonists (may worsen)
• Autoimmune conditions: Immune-modulating peptides
• Seizure disorders: Cerebrolysin (rare exacerbation)

Standard Monitoring Requirements

Peptide Class	Baseline Labs	Follow-up Labs	Frequency
GH Secretagogues	IGF-1, Fasting glucose, HbA1c, Lipid panel	IGF-1, Fasting glucose	4 weeks, then q12 weeks
GLP-1 Agonists	HbA1c, Lipase, Amylase, Renal function, Thyroid panel	HbA1c, Weight, GI symptoms	4 weeks during titration, then q12 weeks
Healing Peptides	CBC, CMP, inflammatory markers (optional)	Clinical assessment	As clinically indicated
Cognitive Peptides	Cognitive assessment, Mood screening	Cognitive assessment, Mood	4 weeks, then q8-12 weeks
Bioregulators	Target organ function (varies by peptide)	Target organ function	q12-16 weeks

Clinical Dosing Principles

Start Low, Go Slow

Begin at minimum effective dose. Titrate based on response and tolerability. Most peptides have wide therapeutic windows.

Individualize Protocols

Adjust for age, weight, renal/hepatic function, and concurrent medications. Genetic polymorphisms may affect response.

Monitor & Document

Track objective biomarkers. Document subjective response. Adjust protocols based on data, not assumptions.

Clinical Resources

Prescriber's Quick Reference Card

Pocket-sized reference with common dosing, interactions, and monitoring

PubMed Evidence Summaries

Curated research summaries with clinical relevance annotations

Drug Interaction Checker

Check peptide interactions with common medications

Patient Education Materials

Printable handouts for patient counseling

Clinical Disclaimer

Information provided is for educational purposes and clinical decision support. It does not replace clinical judgment or establish a provider-patient relationship. Verify all information before clinical application. Many peptides discussed are used off-label or are available only for research purposes in certain jurisdictions.

Loading dashboard...

🏥 Clinical Resources for Healthcare Providers

Evidence-based protocols, prescribing guidelines, and clinical decision support for medical professionals

Clinical

Professional

Evidence-Based

Protocols

For Healthcare Professionals

Quick Access

Prescriber's Guide

Quick reference for dosing & protocols

Evidence Database

Peer-reviewed research summaries

Drug Interactions

Contraindications & interactions

Patient Monitoring

Lab panels & follow-up protocols

Evidence Level Classification

Our evidence grading system follows standard clinical research hierarchies

Strong evidence from multiple RCTs or meta-analyses

Moderate evidence from limited RCTs or well-designed studies

Limited evidence from observational studies or case series

Expert opinion or mechanistic rationale only

Clinical Protocols by Category

Tissue Repair

BPC-157 Acute Injury Protocol

Tendon/ligament injury

Evidence: Level B

TB-500 Systemic Healing Protocol

Multiple site injuries

Evidence: Level B

Post-Surgical Recovery Protocol

Accelerated wound healing

Evidence: Level C

Metabolic

Semaglutide Titration Protocol

Obesity, T2DM

Evidence: Level A

Tirzepatide Weight Management

Obesity, metabolic syndrome

Evidence: Level A

MOTS-c Metabolic Optimization

Metabolic dysfunction

Evidence: Level C

Cognitive

Semax Cognitive Enhancement

Cognitive decline, TBI recovery

Evidence: Level B

Cerebrolysin Neurorehabilitation

Stroke, TBI, dementia

Evidence: Level A

Selank Anxiety Protocol

GAD, stress-related disorders

Evidence: Level B

Hormonal

CJC-1295/Ipamorelin GH Optimization

GH deficiency, anti-aging

Evidence: Level B

Tesamorelin Lipodystrophy

HIV lipodystrophy, visceral fat

Evidence: Level A

PT-141 Sexual Dysfunction

Hypoactive sexual desire

Evidence: Level A

Key Clinical Considerations

Absolute Contraindications

• Active malignancy: GH secretagogues, TB-500 (angiogenesis)
• Pregnancy/Lactation: Most peptides (insufficient safety data)
• Severe renal impairment: Cerebrolysin, some GLP-1 agonists
• Personal/family history MTC: GLP-1 receptor agonists
• MEN 2 syndrome: GLP-1 receptor agonists

Relative Contraindications

• Diabetic retinopathy: GH secretagogues (monitor closely)
• History of pancreatitis: GLP-1 agonists (use caution)
• Gastroparesis: GLP-1 agonists (may worsen)
• Autoimmune conditions: Immune-modulating peptides
• Seizure disorders: Cerebrolysin (rare exacerbation)

Standard Monitoring Requirements

Peptide Class	Baseline Labs	Follow-up Labs	Frequency
GH Secretagogues	IGF-1, Fasting glucose, HbA1c, Lipid panel	IGF-1, Fasting glucose	4 weeks, then q12 weeks
GLP-1 Agonists	HbA1c, Lipase, Amylase, Renal function, Thyroid panel	HbA1c, Weight, GI symptoms	4 weeks during titration, then q12 weeks
Healing Peptides	CBC, CMP, inflammatory markers (optional)	Clinical assessment	As clinically indicated
Cognitive Peptides	Cognitive assessment, Mood screening	Cognitive assessment, Mood	4 weeks, then q8-12 weeks
Bioregulators	Target organ function (varies by peptide)	Target organ function	q12-16 weeks

Clinical Dosing Principles

Start Low, Go Slow

Begin at minimum effective dose. Titrate based on response and tolerability. Most peptides have wide therapeutic windows.

Individualize Protocols

Adjust for age, weight, renal/hepatic function, and concurrent medications. Genetic polymorphisms may affect response.

Monitor & Document

Track objective biomarkers. Document subjective response. Adjust protocols based on data, not assumptions.

Clinical Resources

Prescriber's Quick Reference Card

Pocket-sized reference with common dosing, interactions, and monitoring

PubMed Evidence Summaries

Curated research summaries with clinical relevance annotations

Drug Interaction Checker

Check peptide interactions with common medications

Patient Education Materials

Printable handouts for patient counseling

Clinical Disclaimer

Peptide Engine | The Complete Guide to Peptides, Biohacking & Longevity Medicine